Burcon
-
Burcon files Nasdaq listing application
Burcon NutraScience has filed an application to list its common shares on the Nasdaq Stock Market and a registration statement for its common shares with the US Securities and Exchange Commission (SEC).
Burcon | 26 September 2011
-
Burcon announces new director
Burcon NutraScience Corp appoints Matthew Hall to its board of directors, who recently returned to Canada from Europe, where he spent 31 years with Nestle. He was the MD and CEO of the food, coffee and beverages division of Nestle UK. He was pr…
Burcon | 04 August 2011
-
Burcon NutraScience Corp lists year's of work
Of the highlights of the year, Burcon NutraScience Corp received a no objection letter from the US Food and Drug Administration (FDA) that Puratein and Supertein are generally recognized as safe (GRAS) under their intended conditions of use. It he…
Burcon | 28 June 2011
-
Burcon and ADM partner on protein technology
Burcon NutraScience Corp has entered into a license agreement with Archer Daniels Midland Company (ADM) for the worldwide production, distribution and sale of Burcon's Clarisoy soy protein. The soy protein product is 100% soluble, transparent and…
Burcon | 22 March 2011
-
ADM plans to produce and sell Clarisoy worldwide
Burcon NutraScience Corp said it has signed a non-binding letter of intent with Archer Daniels Midland Company (ADM) that details the intention of the two parties to enter into a license agreement. Under the terms of the agreement, Burcon will lic…
Burcon | 16 November 2010
-
Burcon updates on business activities
Burcon NutraScience Corp has raised gross proceeds of $16.9 million through a public offering of 2,942,950 common shares at $5.75 per share in June 2009. This is part of the financial results for the fiscal year ended March 31, 2010. The compan…
Burcon | 19 July 2010
-
Burcon NutraScience files GRAS notification and receives patent grant
Burcon NutraScience Corp says a formal notification in accordance with the US Food & Drug Administration (FDA) proposed regulation 62FR 18938 has been filed, having determined, based on a review of the data referenced in the notification that Puratei…
Burcon | 21 January 2010
-
Burcon announces new director and patent grants
Burcon NutraScience Corp announces the appointment of Dr. D. Lorne Tyrrell to its board of directors. D. Lorne Tyrrell is the Canadian Institute of Health Research (CIHR)/Glaxo SmithKline Chair in Virology in the Department of Medical Microbiolog…
Burcon | 10 December 2009
-
Burcon announces publication of Supertein toxicology study
Burcon NutraScience Corp announces the publication of a peer-reviewed manuscript describing a toxicology study of Supertein canola protein isolate. The study was conducted to establish the safety of the ingredient in food and beverage applications…
Burcon | 09 November 2009
-
Burcon receives US patent for Puratein
Burcon NutraScience Corp says it has received a notice of allowance from the US Patent and Trademark Office for a patent application covering the composition of the dominant species of protein in its Puratein canola protein isolate. Puratein is a …
Burcon | 01 October 2009
